Relevant bibliographies by topics / Reducing cardiovascular risk factors / Books
To see the other types of publications on this topic, follow the link: Reducing cardiovascular risk factors.

Books on the topic 'Reducing cardiovascular risk factors'

Author: Grafiati
Published: 4 June 2021
Last updated: 13 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Reducing cardiovascular risk factors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Reducing cardiovascular risk in people with diabetes mellitus. Dartford: Magister Consulting, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

P, De Bono D., ed. Cardiovascular risk factors. London: Gower Medical Pub., 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Eades, Mary Dan. Arthritis: Reducing your risk. New York: Bantam Books, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Cicero, Arrigo F. G. Hypertension and Metabolic Cardiovascular Risk Factors. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-39504-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Gotto, Antonio M., Claude Lenfant, Rodolfo Paoletti, and Maurizio Soma, eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht: Springer Netherlands, 1992. http://dx.doi.org/10.1007/978-94-011-2700-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gotto, A. M., C. Lenfant, A. L. Catapano, and R. Paoletti, eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0039-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gotto, Antonio M., C. Lenfant, Rodolfo Paoletti, A. L. Catapano, and A. S. Jackson, eds. Multiple Risk Factors in Cardiovascular Disease. Dordrecht: Springer Netherlands, 1998. http://dx.doi.org/10.1007/978-94-011-5022-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Clinical manual of total cardiovascular risk. London: Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1959-, Osborn Kevin, and Philip Lief Group, eds. Heart disease: Reducing your risk. New York: Bantam Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Eades, Mary Dan. Breast cancer: Reducing your risk. New York: Bantam Books, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Roehrig, Karla L. Risk factors and disease prevention. Columbus, Ohio (456 Clinic Dr., Columbus 43210): Dept. of Family Medicine, College of Medicine, Ohio State University, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Berne, Robert M. Cardiovascular physiology. 5th ed. St. Louis: Mosby, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Contemporary cardiovascular disease risk factors in special populations. Newtown, Pa: Handbooks in Health Care, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Problem solving in cardiovascular risk. Oxford: Clinical Pub., 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Association, American Heart, ed. Metabolic risk for cardiovascular disease. Dallas, TX: American Heart Association, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Marie, Lindquist, and Philip Lief Group, eds. Ovarian and uterine cancer: Reducing your risk. New York: Bantam Books, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Young, T. Kue. Cardiovascular diseases and risk factors among North American Indians. Winnipeg: Northern Health Research Unit, Dept. of Community Health Sciences, Faculty of Medicine, University of Manitoba, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Armitage, Jeff. Impact of cardiovascular disease in Nebraska. Lincoln, Neb.]: Nebraska Health and Human Services System, Dept. of Health and Human Services, Office of Disease Prevention and Health Promotion, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Waters, Anne-Marie. Risk factors for cardiovascular disease: A summary of Australian data. [Canberra]: Australian Institute of Health and Welfare, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Iacobellis, Gianluca. Obesity and cardiovascular disease. Oxford: Oxford University Press, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Eisenberg, Michael. A statewide strategy for reducing youth risk factors related to criminality. Austin, Tex. (P.O. Box 13332, Austin 78711-3332): Criminal Justice Policy Council, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

World Health Organization (WHO). Prevention of cardiovascular disease: Guidelines for assessment and management of cardiovascular risk. Geneva: World Health Organization, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

Adams, Mary L. Cardiovascular disease risk factors in Wyoming: Results from the 2003 Wyoming behavioral risk factor surveillance system. Cheyenne, Wyo.]: Published by the Preventive Health and Safety Division, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Adams, Mary. Cardiovascular disease in Connecticut: Morbidity and risk factors from the 1994 BRFSS. Hartford, Conn: State of Connecticut Dept. of Public Health, Bureau of Community Health, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Quality, United States Agency for Healthcare Research and. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Rockville, Md.]: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

Banerjee, Amitava, and Kaleab Asrress. Prevention of cardiovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0343.

Full text
Abstract:
The global scale of the cardiovascular disease epidemic is unquestionable, with cardiovascular disease causing a greater burden of mortality and morbidity than any other disease, regardless of country or population. With demographic change and ageing populations, the prevalence of cardiovascular disease and its risk factors is set to increase. The commonest cardiovascular diseases are atherosclerotic, affecting all arterial territories. The ‘burden of disease’ approach has highlighted the fact that cardiovascular disease and non-communicable diseases are not simply diseases of affluence but affect people of all countries, with enormous costs in terms of public health, healthcare, and overall economies. Coronary artery disease is the leading cause of mortality in all regions of the world apart from sub-Saharan Africa, followed by cerebrovascular disease. It should be noted, however, that there has been a major decline in cardiovascular disease mortality in Western Europe, the US, and Japan over the past 40 years. There are multiple factors underlying these favourable trends but understanding the epidemiology and characterizing individual risk factors for cardiovascular disease has been central in formulating preventive and treatment strategies. The INTERHEART study showed that 90% of cardiovascular risk can be explained by nine easily identifiable risk factors; an awareness of these, and the discovery of novel factors, will continue to serve in the fight to reduce the burden of cardiovascular disease. Geoffrey Rose first championed population-wide approaches versus strategies which target only high-risk individuals. Prevention aims to ‘catch the disease’ upstream, therefore delaying, reducing, or eliminating the risk of coronary artery disease. Surrogate markers for coronary artery disease have emerged in efforts to detect disease at earlier stages, and in order to better understand the pathophysiology. For example, coronary artery calcium scoring is emerging as a marker of future risk of coronary artery disease. Risk stratification scores are increasingly used as tools to individualize a person’s future risk of coronary artery disease in order to better target treatment and prevention strategies.
APA, Harvard, Vancouver, ISO, and other styles
28

Bono, David P. De, and John D. Swales. Cardiovascular Risk Factors. C.V. Mosby, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Gasparyan, Armen Yuri, ed. Cardiovascular Risk Factors. InTech, 2012. http://dx.doi.org/10.5772/1079.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Kotseva, Kornelia, Neil Oldridge, and Massimo F. Piepoli. Evaluation of preventive cardiology. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0026.

Full text
Abstract:
The Joint European Societies guidelines on cardiovascular disease (CVD) prevention define lifestyle and risk factor targets for patients with coronary or other atherosclerotic disease and people at high risk of developing CVD. However, several surveys in Europe and the United States showed inadequate lifestyle and risk factor management and under-use of prophylactic drug therapies in primary and secondary CVD prevention. Various professional associations have developed core components, standards, and outcome measures to evaluate quality of care and provide guidelines for identifying opportunities for improvements. Optimal control of cardiovascular risk factors is one of the most effective methods for reducing vascular events in patients with atherosclerotic disease or high cardiovascular risk. Improving treatment adherence is also very important. Health-related quality of life (HRQL) is considered as an outcome measure in research studies and in clinical practice. HRQL measures can help in improving patient-clinician communication, screening, monitoring, and continuous assessment of quality of care.
APA, Harvard, Vancouver, ISO, and other styles
31

Kotseva, Kornelia, Neil Oldridge, and Massimo F. Piepoli. Evaluation of preventive cardiology. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199656653.003.0026_update_001.

Full text
Abstract:
The Joint European Societies guidelines on cardiovascular disease (CVD) prevention define lifestyle and risk factor targets for patients with coronary or other atherosclerotic disease and people at high risk of developing CVD. However, several surveys in Europe and the United States showed inadequate lifestyle and risk factor management and under-use of prophylactic drug therapies in primary and secondary CVD prevention. Various professional associations have developed core components, standards, and outcome measures to evaluate quality of care and provide guidelines for identifying opportunities for improvements. Optimal control of cardiovascular risk factors is one of the most effective methods for reducing vascular events in patients with atherosclerotic disease or high cardiovascular risk. Improving treatment adherence is also very important. Health-related quality of life (HRQL) is considered as an outcome measure in research studies and in clinical practice. HRQL measures can help in improving patient-clinician communication, screening, monitoring, and continuous assessment of quality of care.
APA, Harvard, Vancouver, ISO, and other styles
32

Giuseffi, Jennifer, John McPherson, Chad Wagner, and E. Wesley Ely. Acute cognitive disorders: recognition and management of delirium in the cardiovascular intensive care unit. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199687039.003.0074.

Full text
Abstract:
Delirium is the most common acute cognitive disorder seen in critically ill patients in the cardiovascular intensive care unit. It is defined as a disturbance of consciousness and cognition that develops suddenly and fluctuates over time. Delirious patients can become hyperactive, hypoactive, or both. The occurrence of delirium during hospitalization is associated with increased in-hospital and long-term morbidity and mortality. The cause of delirium is multifactorial and may include imbalances in neurotransmitters, inflammatory mediators, metabolic disturbances, impaired sleep, and the use of sedatives and analgesics. Patients with advanced age, dementia, chronic illness, extensive vascular disease, and low cardiac output are at particular risk of developing delirium. Specialized bedside assessment tools are now available to rapidly diagnose delirium, even in mechanically ventilated patients. Increased awareness of delirium risk factors, in addition to non-pharmacological and pharmacological treatments for delirium, can be effective in reducing the incidence of delirium in cardiac patients and in minimizing adverse outcomes, once delirium occurs.
APA, Harvard, Vancouver, ISO, and other styles
33

McPherson, John, Jennifer Giuseffi, Chad Wagner, and E. Wesley Ely. Acute cognitive disorders: recognition and management of delirium in the cardiovascular intensive care unit. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199687039.003.0074_update_001.

Full text
Abstract:
Delirium is the most common acute cognitive disorder seen in critically ill patients in the cardiovascular intensive care unit. It is defined as a disturbance of consciousness and cognition that develops suddenly and fluctuates over time. Delirious patients can become hyperactive, hypoactive, or both. The occurrence of delirium during hospitalization is associated with increased in-hospital and long-term morbidity and mortality. The cause of delirium is multifactorial and may include imbalances in neurotransmitters, inflammatory mediators, metabolic disturbances, impaired sleep, and the use of sedatives and analgesics. Patients with advanced age, dementia, chronic illness, extensive vascular disease, and low cardiac output are at particular risk of developing delirium. Specialized bedside assessment tools are now available to rapidly diagnose delirium, even in mechanically ventilated patients. Increased awareness of delirium risk factors, in addition to non-pharmacological and pharmacological treatments for delirium, can be effective in reducing the incidence of delirium in cardiac patients and in minimizing adverse outcomes, once delirium occurs.
APA, Harvard, Vancouver, ISO, and other styles
34

Connolly, Susan, and Margaret E. Cupples. Community-based prevention centres. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0025.

Full text
Abstract:
The need for a new approach to cardiovascular disease prevention, both secondary and primary, that is different from traditional health service provision through hospital cardiac rehabilitation services and general practice is evident. The targets set in the cardiovascular prevention guidelines for modifiable cardiovascular risk factors-smoking, diet and physical activity, weight and its distribution, blood pressure, lipids, and diabetes-are not being adequately achieved for either coronary or other vascular patients or for those at high multifactorial risk of developing CVD. There is also evidence of an increasing disparity in levels of risk between different community groups, largely attributable to social determinants of health. Community-based prevention centres provide a novel approach to reducing cardiovascular risk, in which there is shared working between professionals and the public and a shared understanding of the barriers that individuals experience in their attempts to engage in effective measures for both secondary and primary prevention.
APA, Harvard, Vancouver, ISO, and other styles
35

(Editor), Neil Poulter, Simon Thom (Editor), and Peter Sever (Editor), eds. Cardiovascular Disease: Risk Factors & Intervention. Scovill-Paterson, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
36

1961-, Gaziano J. Michael, ed. Atlas of cardiovascular risk factors. Philadelphia: Developed by Current Medicine, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

Banerjee, Amitava, and Kaleab Asrress. Risk factors for cardiovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0086.

Full text
Abstract:
The most prevalent cardiovascular diseases (CVDs) are atherosclerotic, affecting all arterial territories. Epidemiologic studies such as the Framingham and INTERHEART studies have firmly established the commonest or ‘traditional’ risk factors for CVD; namely, smoking, hypertension, diabetes mellitus, hypercholesterolaemia, and a family history of CVD. The ‘risk-factors approach’ to CVD looks at these factors, individually and in combination, in the causation of disease. The complex causation pathways involve interplay of individual factors, whether genetic or environmental. More recently, there has been increasing interest in ‘epigenetics’ or the way in which the environment interacts with genes in the process underlying CVD. This chapter presents an analysis of the traditional and novel risk factors for CVD.
APA, Harvard, Vancouver, ISO, and other styles
38

Atlas of cardiovascular risk factors. Philadelphia, PA: Current Medicine, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Cardiovascular Risk Factors [Working Title]. IntechOpen, 2021. http://dx.doi.org/10.5772/intechopen.94673.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Edun, Babatunde, Michelle K. Haas, Christopher Brendemuhl, Jason V. Baker, and Anthony C. Speights. Health Maintenance. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190493097.003.0012.

Full text
Abstract:
The introduction of highly potent antiretroviral agents has transformed HIV from a disease with a once dismal prognosis to a manageable chronic medical condition. The primary care provider as well as the HIV care provider must focus on aspects of preventive medicine that improve the quality of life and life expectancy of the HIV-infected person. Accurate record-keeping is essential, and examples of HIV primary care flow sheets are presented in this chapter. In addition, tuberculosis screening indications and methods are reviewed. Regular preventative dental and gynecological care should be given. Reviewing the treatment of traditional cardiovascular risk factors with patients will be helpful in educating them and reducing the risk of cardiovascular disease.
APA, Harvard, Vancouver, ISO, and other styles
41

Neil, Poulter, Sever Peter S, and Thom Simon, eds. Cardiovascular disease: Risk factors and intervention. Oxford: Radcliffe Medical Press, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
42

Akira, Yamamoto, ed. Multiple risk factors in cardiovascular disease. Edinburgh: Churchill Livingstone, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

Wu, Wenbiao. Dietary Risk Factors of Cardiovascular Diseases. Nova Science Publishers, Incorporated, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Clinician's Manual on Cardiovascular Risk Factors. Science Press Ltd, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
45

Atiq, Mehnaz, ed. Recent Advances in Cardiovascular Risk Factors. InTech, 2012. http://dx.doi.org/10.5772/2495.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

M, Gotto Antonio, ed. Multiple risk factors in cardiovascular disease. Dordrecht: Kluwer Academic Publishers, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Gotto, Antonio M. Multiple Risk Factors in Cardiovascular Disease. Ingramcontent, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
48

Arrigo F. G. F. G. Cicero. Hypertension and Metabolic Cardiovascular Risk Factors. Springer, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Albus, Christian, and Christoph Herrmann-Lingen. Behaviour and motivation. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780199656653.003.0009.

Full text
Abstract:
Changing one’s lifestyle is difficult and adherence to medication in people at high cardiovascular risk and established cardiovascular disease is low. Lifestyle is usually based on longstanding patterns and is highly determined by social environment and socioeconomic status. Additional factors such as chronic stress, cognitive impairment, and negative emotions (e.g. depression, anxiety) further impede the ability to adopt a healthy lifestyle, as does complex or confusing advice by medical caregivers. In clinical practice, increased awareness of these factors will facilitate empathetic counselling and the provision of simple and explicit advice. Established cognitive-behavioural strategies are important tools to help with behaviour change and medication adherence. Specialized healthcare professionals (e.g. nurses, dieticians, psychologists) should be involved whenever necessary and feasible. Reducing dosage demands to the lowest applicable level is the single most effective means for enhancing adherence to medication.
APA, Harvard, Vancouver, ISO, and other styles
50

Albus, Christian, and Christoph Herrmann-Lingen. Behaviour and motivation. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199656653.003.0009_update_001.

Full text
Abstract:
Changing one’s lifestyle is difficult and adherence to medication in people at high cardiovascular risk and established cardiovascular disease is low. Lifestyle is usually based on longstanding patterns and is highly determined by social environment and socioeconomic status. Additional factors such as chronic stress, cognitive impairment, and negative emotions (e.g. depression, anxiety) further impede the ability to adopt a healthy lifestyle, as does complex or confusing advice by medical caregivers. In clinical practice, increased awareness of these factors will facilitate empathetic counselling and the provision of simple and explicit advice. Established cognitive-behavioural strategies are important tools to help with behaviour change and medication adherence. Specialized healthcare professionals (e.g. nurses, dieticians, psychologists) should be involved whenever necessary and feasible. Reducing dosage demands to the lowest applicable level is the single most effective means for enhancing adherence to medication.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Reducing cardiovascular risk factors' for other source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography